Nature Reviews Rheumatology (2020) https://doi.org/10.1038/s41584-020-0458-5 Published online 05 August 2020
In the originally published version of this article, an incorrect description of the Polymyalgia Rheumatica Activity Score (PMR-AS) was given. The sentence “This score is based on the patient’s and physician’s global assessment, morning stiffness, the ability of the patient to elevate the arms and CRP levels” has been corrected to “This score is based on the patient’s pain assessment, physician’s global assessment, morning stiffness, the ability of the patient to elevate the arms and CRP levels.” This has been corrected in the HTML and PDF versions of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Camellino, D., Matteson, E.L., Buttgereit, F. et al. Author Correction: Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica. Nat Rev Rheumatol 16, 662 (2020). https://doi.org/10.1038/s41584-020-00505-x
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41584-020-00505-x
This article is cited by
-
The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future Prospects
Rheumatology and Therapy (2025)